Your browser doesn't support javascript.
loading
Humoral antibody response to the first dose of the ChAdOx1 nCoV-19 vaccine in Asian patients undergoing hemodialysis.
Tung, Kuei-Ting; Peng, Yu-Sen; Hsu, Shih-Ping; Wu, Hon-Yen; Chiu, Yen-Ling; Yang, Ju-Yeh; Pai, Mei-Fen; Shu, Kai-Hsiang; Pan, Szu-Yu; Lu, Hui-Ming; Lin, Wan-Yu; Liao, Chun-Hsing; Chu, Fang-Yeh; Tsai, Wan-Chuan.
Afiliación
  • Tung KT; Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
  • Peng YS; Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
  • Hsu SP; Department of Applied Cosmetology, Lee-Ming Institute of Technology, New Taipei City, Taiwan.
  • Wu HY; Department of Healthcare Administration, Asia Eastern University of Science and Technology, New Taipei City, Taiwan.
  • Chiu YL; Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
  • Yang JY; School of Life Science, National Taiwan Normal University, Taipei City, Taiwan.
  • Pai MF; Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
  • Shu KH; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei City, Taiwan.
  • Pan SY; School of Medicine, College of Medicine, National Yang-Ming Chiao Tung University, Taipei City, Taiwan.
  • Lu HM; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei City, Taiwan.
  • Lin WY; Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
  • Liao CH; Graduate Program in Biomedical Informatics, Yuan Ze University, Taoyuan City, Taiwan.
  • Chu FY; Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
  • Tsai WC; Division of Nephrology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Hemodial Int ; 26(3): 369-376, 2022 07.
Article en En | MEDLINE | ID: mdl-35411681
ABSTRACT
BACKGROUND AND

OBJECTIVES:

The immunogenicity of vaccines is known to be attenuated in patients with end-stage kidney disease due to uremia. Patients on dialysis were excluded from coronavirus disease 2019 (COVID-19) vaccine trials; thus, the effectiveness of vaccines for this population is unclear. The aim of this study was to explore whether Asian dialysis patients can effectively produce an immune response after being vaccinated with the first dose of the ChAdOx1 nCoV-19 vaccine. DESIGN SETTING, PARTICIPANTS, AND MEASUREMENTS In this prospective cohort study, we included Asian hemodialysis patients who received the ChAdOx1 nCoV-19 vaccine. At 3 weeks after the first dose of vaccination, we assessed the humoral immune response by measuring anti-SARS-CoV-2 S antibody titers. The primary outcome was the seropositive rate following vaccination, defined as an antibody titer greater than or equal to 0.8 U/ml. Factors associated with seropositivity were explored in multivariate logistic regression analyses.

RESULTS:

In total, 434 participants were included. The mean age was 64 years, the mean dialysis vintage was 6 years, and 61% of the participants were men. At a mean time of 22 days from vaccination, 56% of the participants were seropositive. The vast majority (88%) had low antibody titers (< 15 U/ml). The multivariate logistic regression analyses showed that older age (every increase of 10 years, odds ratio [OR] 0.80, 95% CI 0.65-0.98, p = 0.03) was negatively associated with seropositivity and that higher Kt/V (every increase of 0.1, OR 1.14, 95% CI 1.01-1.28, p = 0.03) and higher serum albumin level (every increase of 0.1 g/dl, OR 1.09, 95% CI 1.02-1.18, p = 0.02) were positively associated with seropositivity.

CONCLUSIONS:

In Asian hemodialysis patients, the seropositive rate was low, and most had low antibody titers after the first dose of the ChAdOx1 nCoV-19 vaccine. Younger age, better dialysis adequacy, and higher albumin levels were associated with seropositivity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Hemodial Int Asunto de la revista: NEFROLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Hemodial Int Asunto de la revista: NEFROLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Taiwán
...